The DOI matches its Crossref record.
Cloning, Pharmacological Characterization and Brain Distribution of the Rat Apelin Receptor
Abstract
The peptide apelin, recently isolated from bovine stomach tissue extracts, has been identified as an endogenous ligand of the human putative receptor protein related to the angiotensin receptor AT 1 (APJ). In this article, we report cloning of the rat apelin receptor cDNA. The sequence shares 90% identity with the human APJ receptor and 31% with the rat AT 1A angiotensin receptor. Subsequently a stable CHO cell line expressing the receptor fused at its C-terminal part with the enhanced green fluorescent protein (EGFP) was established, allowing to verify its cell surface distribution and to determine the affinity of various apelin and angiotensin fragments on the cloned receptor. As shown for the human APJ receptor, the rat apelin receptor expressed in the cell line was negatively coupled to adenylate cyclase. The apelin fragment K17F (Lys 1-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe 17) inhibited forskolin-stimulated cAMP production at sub-nanomolar concentrations whereas angiotensin II and angiotensin III were inactive. N-terminal elongation of K17F with a tyrosine or the N-terminal deletion of the first four amino acids did not modify the inhibitory action of K17F on cAMP production. In contrast, deletion of the first seven amino acids of K17F or substitution of phenylalanine by an alanine residue at the C-terminus completely abolished the activity of the peptide. In situ hybridization analysis of apelin receptor mRNA expression in the adult rat brain showed intense labeling in the hypothalamus, especially in the supraoptic and the paraventricular nuclei. The anterior and intermediate lobes of the pituitary were also highly labeled, as well as the pineal gland. Labeling was also found in extrahypothalamic structures such as the piriform cortex, the nucleus of the lateral olfactory tract, the central grey matter, the pars compacta of the substantia nigra, the dorsal raphe nucleus, the entorhinal cortex, the dentate gyrus and the Ammon’s horn. The hypothalamic and hypophyseal distribution of the receptor suggests an involvement of apelin in the control of neuro- and adenohypophyseal hormone release, whereas its presence in the pineal gland and in discrete higher brain structures points out to possible roles in the regulation of circadian rhythms and of water and food intake behavior.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Simonneaux, V., & Ribelayga, C. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.2 · Cited by 740
Medhurst, A. D., Jennings, C. A., Robbins, M. J., Davis, R. P., Ellis, C., Winborn, K. Y., Lawrie, K. W. M., Hervieu, G., Riley, G., Bolaky, J. E., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01587.x · Cited by 448
Emerging roles of apelin in biology and medicine
Kleinz, M. J., & Davenport, A. P. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.001 · Cited by 413
Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain
Reaux, A., De Mota, N., Skultetyova, I., Lenkei, Z., El Messari, S., Gallatz, K., Corvol, P., Palkovits, M., & Llorens‐Cortès, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00320.x · Cited by 374
Self-citationYin, J., Li, G., Ren, X., & Herrler, G. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.07.012 · Cited by 373
De Mota, N., Reaux-Le Goazigo, A., El Messari, S., Chartrel, N., Roesch, D., Dujardin, C., Kordon, C., Vaudry, H., Moos, F., & Llorens-Cortes, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403518101 · Cited by 366
Self-citationASHLEY, E., POWERS, J., CHEN, M., KUNDU, R., FINSTERBACH, T., CAFFARELLI, A., DENG, A., EICHHORN, J., MAHAJAN, R., & AGRAWAL, R. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.08.018 · Cited by 345
The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis
O'Carroll, A.-M., Lolait, S. J., Harris, L. E., & Pope, G. R. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0227 · Cited by 344
Taheri, S., Murphy, K., Cohen, M., Sujkovic, E., Kennedy, A., Dhillo, W., Dakin, C., Sajedi, A., Ghatei, M., & Bloom, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6575 · Cited by 314
Kleinz, M. J., Skepper, J. N., & Davenport, A. P. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.10.019 · Cited by 297
Kleinz, M. J., & Davenport, A. P. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2003.11.002 · Cited by 288
Modification of the Terminal Residue of Apelin-13 Antagonizes Its Hypotensive Action
Lee, D. K., Saldivia, V. R., Nguyen, T., Cheng, R., George, S. R., & O’Dowd, B. F. (2005) · Endocrinology · doi:10.1210/en.2004-0359 · Cited by 256
Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding
Heinonen, M. V., Purhonen, A. K., Miettinen, P., Pääkkönen, M., Pirinen, E., Alhava, E., Åkerman, K., & Herzig, K. H. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.05.003 · Cited by 232
Sancandi, M., Uysal-Onganer, P., Kraev, I., Mercer, A., & Lange, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082743 · Cited by 41
Knauf, C., Drougard, A., Fournel, A., Duparc, T., & Valet, P. (2013) · Hormone and Metabolic Research · doi:10.1055/s-0033-1351321 · Cited by 38
Metadata
- Authors
- De Mota, N., Lenkei, Z., & Llorens-Cortès, C.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2000
- Volume
- 72
- Issue
- 6
- Pages
- 400-407
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2043354554
- Cited by
- 218
- References
- 0
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.